Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal)

Technology appraisal
Reference number: TA438
Published: 29 March 2017

History

Draft scope documents

Draft scope (pre-referral) (PDF 172 KB)

Published:

06 July 2016
Provisional matrix (pre-referral) (PDF 97 KB)

Published:

06 July 2016

Invitation to participate

Final scope (PDF 109 KB)

Published:

06 July 2016
Final matrix (PDF 98 KB)

Published:

06 July 2016
NICE's response to comments on the draft scope and provisional matrix (PDF 147 KB)

Published:

06 July 2016